{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T22:01:16Z","timestamp":1774648876218,"version":"3.50.1"},"reference-count":74,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":710,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1002\/jcph.167","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T14:16:55Z","timestamp":1377267415000},"page":"121-132","source":"Crossref","is-referenced-by-count":35,"title":["Pharmacokinetics of lopinavir\/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in tororo, uganda"],"prefix":"10.1002","volume":"54","author":[{"given":"Imke H.","family":"Bartelink","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy; Drug Research Unit, University of California; San Francisco CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rada M.","family":"Savic","sequence":"additional","affiliation":[{"name":"Department of Bioengineering & Therapeutic Sciences of the University of California; San Francisco CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Mwesigwa","sequence":"additional","affiliation":[{"name":"Makerere University, University of California San Francisco Research Collaboration, The Makerere University Kampala; Kampala Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Achan","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Makerere University Kampala; Kampala Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Medicine of the University of California; San Francisco CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Plenty","sequence":"additional","affiliation":[{"name":"Center for AIDS Prevention Studies of the University of California; San Francisco CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Charlebois","sequence":"additional","affiliation":[{"name":"Center for AIDS Prevention Studies of the University of California; San Francisco CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses","family":"Kamya","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Makerere University Kampala; Kampala Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sera L.","family":"Young","sequence":"additional","affiliation":[{"name":"Division of Nutritional Sciences, Cornell University; Ithaca NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics; Gynecology and Reproductive Sciences of the University of California; San Francisco CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Havlir","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of California, San Francisco (UCSF); USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Cohan","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy; Drug Research Unit, University of California; San Francisco CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Aweeka","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy; Drug Research Unit, University of California; San Francisco CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,9,21]]},"reference":[{"key":"10.1002\/jcph.167-BIB0001|jcph167-cit-0001","unstructured":"http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2012\/gr2012\/20121120_UNAIDS_Global_Report_2012_en.pdf"},{"key":"10.1002\/jcph.167-BIB0002|jcph167-cit-0002","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1017\/S0029665110001990","article-title":"Drug disposition in obesity and protein-energy malnutrition","volume":"69","author":"Boullata","year":"2010","journal-title":"Proc Nutr Soc."},{"key":"10.1002\/jcph.167-BIB0003|jcph167-cit-0003","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2165\/00003088-198900171-00006","article-title":"Drug metabolism and pharmacokinetics in malnourished children","volume":"17","author":"Krishnaswamy","year":"1989","journal-title":"Clin Pharmacokinet."},{"key":"10.1002\/jcph.167-BIB0004|jcph167-cit-0004","doi-asserted-by":"crossref","first-page":"1697S","DOI":"10.3945\/ajcn.111.019109","article-title":"Nutrition and pharmacology: general principles and implications for HIV","volume":"94","author":"Raiten","year":"2011","journal-title":"Am J Clin Nutr."},{"key":"10.1002\/jcph.167-BIB0005|jcph167-cit-0005","unstructured":"http:\/\/www.measuredhs.com\/pubs\/pdf\/FR194\/FR194.pdf"},{"key":"10.1002\/jcph.167-BIB0006|jcph167-cit-0006","doi-asserted-by":"crossref","first-page":"e10340","DOI":"10.1371\/journal.pone.0010340","article-title":"Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda","volume":"5","author":"Weiser","year":"2010","journal-title":"PLoS ONE."},{"key":"10.1002\/jcph.167-BIB0007|jcph167-cit-0007","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-013-0547-4","article-title":"A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS","author":"Young","year":"2013","journal-title":"AIDS Behav"},{"key":"10.1002\/jcph.167-BIB0008|jcph167-cit-0008","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/clpt.2012.137","article-title":"Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients","volume":"92","author":"Savic","year":"2012","journal-title":"Clin Pharmacol Ther."},{"key":"10.1002\/jcph.167-BIB0009|jcph167-cit-0009","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1191\/096228099669221405","article-title":"The impact of compliance in pharmacokinetic studies","volume":"8","author":"Vrijens","year":"1999","journal-title":"Stat Methods Med Res."},{"key":"10.1002\/jcph.167-BIB0010|jcph167-cit-0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0091270004274433","article-title":"Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models","volume":"45","author":"Vrijens","year":"2005","journal-title":"J Clin Pharmacol."},{"key":"10.1002\/jcph.167-BIB0011|jcph167-cit-0011","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/108729103322395465","article-title":"Correlation between lopinavir plasma levels and lipid abnormalities in patients taking lopinavir\/ritonavir","volume":"17","author":"Gonzalez de","year":"2003","journal-title":"AIDS Patient Care STDS."},{"key":"10.1002\/jcph.167-BIB0012|jcph167-cit-0012","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00126334-200308150-00007","article-title":"Lopinavir plasma concentrations and changes in lipid levels during salvage therapy with lopinavir\/ritonavir-containing regimens","volume":"33","author":"Gutierrez","year":"2003","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.167-BIB0013|jcph167-cit-0013","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1468-1293.2006.00354.x","article-title":"Low initial trough plasma concentrations of lopinavir are associated with an impairment of virological response in an unselected cohort of HIV-1-infected patients","volume":"7","author":"Wateba","year":"2006","journal-title":"HIV Med."},{"key":"10.1002\/jcph.167-BIB0014|jcph167-cit-0014","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/01.inf.0000180578.38584.da","article-title":"Pharmacokinetics and 24-week efficacy\/safety of dual boosted saquinavir\/lopinavir\/ritonavir in nucleoside-pretreated children","volume":"24","author":"Ananworanich","year":"2005","journal-title":"Pediatr Infect Dis J."},{"key":"10.1002\/jcph.167-BIB0015|jcph167-cit-0015","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/aid.2006.22.232","article-title":"Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy","volume":"22","author":"Leth","year":"2006","journal-title":"AIDS Res Hum Retroviruses."},{"key":"10.1002\/jcph.167-BIB0016|jcph167-cit-0016","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00007691-200406000-00008","article-title":"Efavirenz plasma concentrations in HIV-infected patients: inter- and intraindividual variability and clinical effects","volume":"26","author":"Stahle","year":"2004","journal-title":"Ther Drug Monit."},{"key":"10.1002\/jcph.167-BIB0017|jcph167-cit-0017","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/AAC.47.1.350-359.2003","article-title":"Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients","volume":"47","author":"Hsu","year":"2003","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1002\/jcph.167-BIB0018|jcph167-cit-0018","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1310\/GMW7-H051-7WH5-2CXH","article-title":"A clinical study of the combination of 100 mg ritonavir plus 800 mg indinavir as salvage therapy: influence of increased plasma drug levels in the rate of response","volume":"1","author":"Casado","year":"2000","journal-title":"HIV Clin Trials"},{"key":"10.1002\/jcph.167-BIB0019|jcph167-cit-0019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00002030-200101050-00011","article-title":"Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients","volume":"15","author":"Marzolini","year":"2001","journal-title":"AIDS"},{"key":"10.1002\/jcph.167-BIB0020|jcph167-cit-0020","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","article-title":"Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients","volume":"76","author":"Ciccarelli","year":"2011","journal-title":"Neurology"},{"key":"10.1002\/jcph.167-BIB0021|jcph167-cit-0021","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1086\/497835","article-title":"Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring","volume":"41","author":"Gutierrez","year":"2005","journal-title":"Clin Infect Dis."},{"key":"10.1002\/jcph.167-BIB0022|jcph167-cit-0022","first-page":"949","article-title":"A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men","volume":"6","author":"Abrams","year":"1993","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.167-BIB0023|jcph167-cit-0023","first-page":"689","article-title":"Nutritional status and survival in HIV-1 disease","volume":"11","author":"Baum","year":"1997","journal-title":"AIDS"},{"key":"10.1002\/jcph.167-BIB0024|jcph167-cit-0024","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/QAI.0b013e3181b32baf","article-title":"Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia","volume":"53","author":"Koethe","year":"2010","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.167-BIB0025|jcph167-cit-0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/QAI.0b013e3181b627c2","article-title":"The association between food insecurity and mortality among HIV-infected individuals on HAART","volume":"52","author":"Weiser","year":"2009","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.167-BIB0026|jcph167-cit-0026","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QAD.0b013e32834cad37","article-title":"Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor setting","volume":"26","author":"Weiser","year":"2012","journal-title":"AIDS"},{"key":"10.1002\/jcph.167-BIB0027|jcph167-cit-0027","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/ajcn\/87.6.1639","article-title":"Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women","volume":"87","author":"Mehta","year":"2008","journal-title":"Am J Clin Nutr."},{"key":"10.1002\/jcph.167-BIB0028|jcph167-cit-0028","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/QAI.0b013e3181d6c9ed","article-title":"Lopinavir tablet pharmacokinetics with an increased dose during pregnancy","volume":"54","author":"Best","year":"2010","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.167-BIB0029|jcph167-cit-0029","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2125.2012.04163.x","article-title":"Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices","volume":"74","author":"Calcagno","year":"2012","journal-title":"Br J Clin Pharmacol."},{"key":"10.1002\/jcph.167-BIB0030|jcph167-cit-0030","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/cid\/cir131","article-title":"Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy","volume":"52","author":"Gandhi","year":"2011","journal-title":"Clin Infect Dis."},{"key":"10.1002\/jcph.167-BIB0031|jcph167-cit-0031","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/QAI.0b013e31820dc0cc","article-title":"Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting","volume":"56","author":"van Zyl","year":"2011","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.167-BIB0032|jcph167-cit-0032","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QAD.0b013e328325a4a9","article-title":"Protease inhibitor levels in hair strongly predict virologic response to treatment","volume":"23","author":"Gandhi","year":"2009","journal-title":"AIDS"},{"key":"10.1002\/jcph.167-BIB0033|jcph167-cit-0033","doi-asserted-by":"crossref","first-page":"e41934","DOI":"10.1371\/journal.pone.0041934","article-title":"Maternal nutritional status predicts adverse birth outcomes among HIV-infected Rural Ugandan women receiving combination antiretroviral therapy","volume":"7","author":"Young","year":"2012","journal-title":"PLoS ONE."},{"key":"10.1002\/jcph.167-BIB0034|jcph167-cit-0034","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1128\/AAC.48.3.979-984.2004","article-title":"Intrapatient variability of efavirenz concentrations as a predictor of virologic response to antiretroviral therapy","volume":"48","author":"Brundage","year":"2004","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1002\/jcph.167-BIB0035|jcph167-cit-0035","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jac\/dks011","article-title":"Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz","volume":"67","author":"Kromdijk","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"10.1002\/jcph.167-BIB0036|jcph167-cit-0036","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1002\/rcm.3750","article-title":"Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry","volume":"22","author":"Huang","year":"2008","journal-title":"Rapid Commun Mass Spectrom."},{"key":"10.1002\/jcph.167-BIB0037|jcph167-cit-0037","first-page":"1","volume-title":"Household food insecurity access scale (HFIAS) for measurement of food access: indicator guide","author":"Coates","year":"2007"},{"key":"10.1002\/jcph.167-BIB0038|jcph167-cit-0038","first-page":"1","article-title":"Introducing a simple mesure of household hunger for cross-cultural use","volume":"2","author":"Deitchler","year":"2011","journal-title":"Tech Note FANTA."},{"key":"10.1002\/jcph.167-BIB0039|jcph167-cit-0039","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2125.2009.03516.x","article-title":"A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans","volume":"68","author":"Mukonzo","year":"2009","journal-title":"Br J Clin Pharmacol."},{"key":"10.1002\/jcph.167-BIB0040|jcph167-cit-0040","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/jac\/dkp123","article-title":"Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment","volume":"63","author":"Bouillon-Pichault","year":"2009","journal-title":"J Antimicrob Chemother."},{"key":"10.1002\/jcph.167-BIB0041|jcph167-cit-0041","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000138174","article-title":"Pharmacokinetics of carbamazepine in protein energy malnutrition","volume":"32","author":"Bano","year":"1986","journal-title":"Pharmacology."},{"key":"10.1002\/jcph.167-BIB0042|jcph167-cit-0042","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2165\/00003088-198106020-00005","article-title":"The effect of malnutrition on the pharmacokinetics of phenylbutazone","volume":"6","author":"Krishnaswamy","year":"1981","journal-title":"Clin Pharmacokinet."},{"key":"10.1002\/jcph.167-BIB0043|jcph167-cit-0043","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02235648","article-title":"Factors affecting gastrointestinal absorption of drugs","volume":"15","author":"Levine","year":"1970","journal-title":"Am J Dig Dis."},{"key":"10.1002\/jcph.167-BIB0044|jcph167-cit-0044","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/01.mco.0000241670.24923.5b","article-title":"The effects of undernutrition and refeeding on metabolism and digestive function","volume":"9","author":"Winter","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1002\/jcph.167-BIB0045|jcph167-cit-0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00042737-200012020-00010","article-title":"The effect of severe undernutrition, and subsequent refeeding on digestive function in human patients","volume":"12","author":"Winter","year":"2000","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1002\/jcph.167-BIB0046|jcph167-cit-0046","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.nutr.20.1.195","article-title":"Intestinal transport during fasting and malnutrition","volume":"20","author":"Ferraris","year":"2000","journal-title":"Annu Rev Nutr."},{"key":"10.1002\/jcph.167-BIB0047|jcph167-cit-0047","doi-asserted-by":"crossref","first-page":"1729S","DOI":"10.3945\/ajcn.111.012070","article-title":"Conceptual framework for understanding the bidirectional links between food insecurity and HIV\/AIDS","volume":"94","author":"Weiser","year":"2011","journal-title":"Am J Clin Nutr."},{"key":"10.1002\/jcph.167-BIB0048|jcph167-cit-0048","first-page":"105980","article-title":"Effect of food on the steady-state pharmacokinetics of tenofovir and emtricitabine plus efavirenz in Ugandan adults","volume":"2012","author":"Lamorde","year":"2012","journal-title":"AIDS Res Treat."},{"key":"10.1002\/jcph.167-BIB0049|jcph167-cit-0049","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/QAI.0b013e3182567a35","article-title":"Steady-state pharmacokinetics of lopinavir plus ritonavir when administered under different meal conditions in HIV-infected Ugandan adults","volume":"60","author":"Lamorde","year":"2012","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.167-BIB0050|jcph167-cit-0050","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ejps.2012.04.004","article-title":"Impact of food administration on lopinavir-ritonavir bioequivalence studies","volume":"46","author":"Ibarra","year":"2012","journal-title":"Eur J Pharm Sci."},{"key":"10.1002\/jcph.167-BIB0051|jcph167-cit-0051","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/QAI.0b013e31803133c5","article-title":"The tablet formulation of lopinavir\/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect","volume":"44","author":"Klein","year":"2007","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.167-BIB0052|jcph167-cit-0052","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2146\/ajhp090327","article-title":"Bioavailability in healthy adults of efavirenz capsule contents mixed with a small amount of food","volume":"67","author":"Kaul","year":"2010","journal-title":"Am J Health Syst Pharm."},{"key":"10.1002\/jcph.167-BIB0053|jcph167-cit-0053","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/adc.52.4.325","article-title":"The stomach in malnutrition","volume":"52","author":"Gracey","year":"1977","journal-title":"Arch Dis Child."},{"key":"10.1002\/jcph.167-BIB0054|jcph167-cit-0054","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1002\/jps.22655","article-title":"Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors","volume":"100","author":"Griffin","year":"2011","journal-title":"J Pharm Sci."},{"key":"10.1002\/jcph.167-BIB0055|jcph167-cit-0055","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1468-1293.2009.00767.x","article-title":"Lopinavir protein binding in HIV-1-infected pregnant women","volume":"11","author":"Aweeka","year":"2010","journal-title":"HIV Med."},{"key":"10.1002\/jcph.167-BIB0056|jcph167-cit-0056","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.2042-7158.1989.tb06503.x","article-title":"Protein binding of salicylic and salicyluric acid in serum from malnourished children: the influence of albumin, competitive binding and non-esterified fatty acids","volume":"41","author":"Ashton","year":"1989","journal-title":"J Pharm Pharmacol."},{"key":"10.1002\/jcph.167-BIB0057|jcph167-cit-0057","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/135965350801300507","article-title":"Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication","volume":"13","author":"Stohr","year":"2008","journal-title":"Antivir Ther."},{"key":"10.1002\/jcph.167-BIB0058|jcph167-cit-0058","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/QAD.0b013e32830163ad","article-title":"Clinical impact of patient population differences and genomic variation in efavirenz therapy","volume":"22","author":"King","year":"2008","journal-title":"AIDS."},{"key":"10.1002\/jcph.167-BIB0059|jcph167-cit-0059","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/COH.0b013e3283339caf","article-title":"Pharmacokinetics of low-dose protease inhibitors and efavirenz in low- and middle-income countries","volume":"5","author":"Gorowara","year":"2010","journal-title":"Curr Opin HIV AIDS."},{"key":"10.1002\/jcph.167-BIB0060|jcph167-cit-0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00003088-200847100-00005","article-title":"Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults","volume":"47","author":"Molto","year":"2008","journal-title":"Clin Pharmacokinet."},{"key":"10.1002\/jcph.167-BIB0061|jcph167-cit-0061","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1097\/01.aids.0000247114.43714.90","article-title":"Reduced lopinavir exposure during pregnancy","volume":"20","author":"Stek","year":"2006","journal-title":"AIDS."},{"key":"10.1002\/jcph.167-BIB0062|jcph167-cit-0062","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/QAI.0b013e318186edd0","article-title":"Lopinavir exposure with an increased dose during pregnancy","volume":"49","author":"Mirochnick","year":"2008","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.167-BIB0063|jcph167-cit-0063","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0b013e31823ff052","article-title":"Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum","volume":"59","author":"Cressey","year":"2012","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.167-BIB0064|jcph167-cit-0064","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/BF02980136","article-title":"Pharmacokinetic changes in drugs during protein-calorie malnutrition: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes","volume":"27","author":"Lee","year":"2004","journal-title":"Arch Pharm Res."},{"key":"10.1002\/jcph.167-BIB0065|jcph167-cit-0065","first-page":"205","article-title":"Disposition of four drugs in malnourished children","volume":"1","author":"Mehta","year":"1982","journal-title":"Drug Nutr Interact."},{"key":"10.1002\/jcph.167-BIB0066|jcph167-cit-0066","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00002030-200106150-00015","article-title":"Non-adherence to highly active antiretroviral therapy predicts progression to AIDS","volume":"15","author":"Bangsberg","year":"2001","journal-title":"AIDS"},{"key":"10.1002\/jcph.167-BIB0067|jcph167-cit-0067","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-139-10-200311180-00008","article-title":"Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350\u2009\u00d7\u200910(9) cells\/L","volume":"139","author":"Wood","year":"2003","journal-title":"Ann Intern Med."},{"key":"10.1002\/jcph.167-BIB0068|jcph167-cit-0068","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","article-title":"Adherence to protease inhibitor therapy and outcomes in patients with HIV infection","volume":"133","author":"Paterson","year":"2000","journal-title":"Ann Intern Med."},{"key":"10.1002\/jcph.167-BIB0069|jcph167-cit-0069","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00042560-200205010-00014","article-title":"Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients","volume":"30","author":"Garcia de Olalla","year":"2002","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/jcph.167-BIB0070|jcph167-cit-0070","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/323201","article-title":"Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring","volume":"33","author":"Arnsten","year":"2001","journal-title":"Clin Infect Dis."},{"key":"10.1002\/jcph.167-BIB0071|jcph167-cit-0071","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/infdis\/jis508","article-title":"A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women","volume":"206","author":"Gandhi","year":"2012","journal-title":"J Infect Dis."},{"key":"10.1002\/jcph.167-BIB0072|jcph167-cit-0072","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1097\/QAD.0b013e32833ce57d","article-title":"Pharmacokinetics and virologic response of zidovudine\/lopinavir\/ritonavir initiated during the third trimester of pregnancy","volume":"24","author":"Cressey","year":"2010","journal-title":"AIDS."},{"key":"10.1002\/jcph.167-BIB0073|jcph167-cit-0073","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/QAD.0b013e328347f7e9","article-title":"Thai HIV-1-infected women do not require a dose increase of lopinavir\/ritonavir during the third trimester of pregnancy","volume":"25","author":"Ramautarsing","year":"2011","journal-title":"AIDS"},{"key":"10.1002\/jcph.167-BIB0074|jcph167-cit-0074","unstructured":"http:\/\/apps.who.int\/bmi\/index.jsp?introPage=intro_3.html"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.167","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcph.167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T01:35:47Z","timestamp":1688434547000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.167"}},"subtitle":["The Journal of Clinical Pharmacology"],"short-title":[],"issued":{"date-parts":[[2013,9,21]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.167","relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,21]]}}}